308 related articles for article (PubMed ID: 8103964)
1. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
Pincus T; Callahan LF
Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
[TBL] [Abstract][Full Text] [Related]
2. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
Pincus T; Marcum SB; Callahan LF
J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
[TBL] [Abstract][Full Text] [Related]
3. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
[No Abstract] [Full Text] [Related]
4. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
[TBL] [Abstract][Full Text] [Related]
5. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs.
Pincus T; Marcum SB; Callahan LF; Adams RF; Barber J; Barth WF; Gordon GV; Huston JW; Polk JR; Whelton JC
J Rheumatol; 1992 Dec; 19(12):1874-84. PubMed ID: 1294734
[TBL] [Abstract][Full Text] [Related]
6. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
[No Abstract] [Full Text] [Related]
7. Rheumatoid arthritis: a pharmacologic overview.
Pinals RS
Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
[TBL] [Abstract][Full Text] [Related]
8. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
Clegg DO; Ward JR
Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
[TBL] [Abstract][Full Text] [Related]
9. [Comparative effectiveness and combined administration of basic drugs in rheumatoid arthritis].
Noskov SM; Kozlov GS
Revmatologiia (Mosk); 1991; (1):26-9. PubMed ID: 1676853
[No Abstract] [Full Text] [Related]
10. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
Criswell LA; Such CL; Yelin EH
J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
12. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
Fries JF; Williams CA; Singh G; Ramey DR
J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
Taha AS; Capell HA; Sturrock RD; Russell RI
Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
[TBL] [Abstract][Full Text] [Related]
14. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
[TBL] [Abstract][Full Text] [Related]
15. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
Kovarsky J
Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
[No Abstract] [Full Text] [Related]
16. Care of the person with rheumatoid arthritis.
Sienknecht CW
Compr Ther; 1990 Apr; 16(4):29-35. PubMed ID: 1970764
[TBL] [Abstract][Full Text] [Related]
17. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
[TBL] [Abstract][Full Text] [Related]
18. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
[No Abstract] [Full Text] [Related]
19. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
[TBL] [Abstract][Full Text] [Related]
20. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
